A novel recurrent mutation in ATP1A3 causes CAPOS syndrome

BackgroundWe undertook genetic analysis of three affected families to identify the cause of dominantly-inherited CAPOS (cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorineural hearing loss) syndrome.MethodsWe used whole-exome sequencing to analyze two families affected with CAPOS syndrome, including the original family reported in 1996, and Sanger sequencing to assess familial segregation of rare variants identified in the probands and in a third, apparently unrelated family with CAPOS syndrome.ResultsWe found an identical heterozygous missense mutation, c.2452G > A (p.(Glu818Lys)), in the Na+/K+ ATPase α3(ATP1A3) gene in the proband and his affected sister and mother, but not in either unaffected maternal grandparent, in the first family. The same mutation was also identified in the proband and three other affected members of the second family and in all three affected members of the third family. This mutation was not found in more than 3600 chromosomes from unaffected individuals.ConclusionOther mutations in ATP1A3 have previously been demonstrated to cause rapid-onset dystonia-parkinsonism (also called dystonia-12) or alternating hemiplegia of childhood. This study shows that an allelic mutation in ATP1A3 produces CAPOS syndrome.

[1]  L. Ozelius Clinical spectrum of disease associated with ATP1A3 mutations , 2012, The Lancet Neurology.

[2]  X. Breakefield,et al.  Rapid‐onset dystonia‐parkinsonism , 1993, Neurology.

[3]  Alan J. Cann Genomes , 2012, Principles of Molecular Virology.

[4]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer , 2011, Nature Biotechnology.

[5]  M. Bublitz P-Type ATPases , 2016, Methods in Molecular Biology.

[6]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[7]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[8]  T. Langmann,et al.  The Na/K-ATPase is obligatory for membrane anchorage of retinoschisin, the protein involved in the pathogenesis of X-linked juvenile retinoschisis. , 2011, Human molecular genetics.

[9]  E. Glowatzki,et al.  Distribution of the Na,K-ATPase α Subunit in the Rat Spiral Ganglion and Organ of Corti , 2009, Journal of the Association for Research in Otolaryngology.

[10]  David B. Goldstein,et al.  De novo mutations in ATP1A3 cause alternating hemiplegia of childhood , 2012, Nature Genetics.

[11]  William B Dobyns,et al.  Mutations in the Na+/K+-ATPase α3 Gene ATP1A3 Are Associated with Rapid-Onset Dystonia Parkinsonism , 2004, Neuron.

[12]  Alexander Münchau,et al.  The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. , 2007, Brain : a journal of neurology.

[13]  Helga Thorvaldsdóttir,et al.  Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[14]  Steven J. M. Jones,et al.  Mutations in EZH2 cause Weaver syndrome. , 2012, American journal of human genetics.

[15]  P. Nissen,et al.  Na+,K+-ATPase as a docking station: protein–protein complexes of the Na+,K+-ATPase , 2012, Cellular and Molecular Life Sciences.

[16]  Hugo Gutiérrez-de-Terán,et al.  A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. , 2009, Human molecular genetics.

[17]  Peter Nürnberg,et al.  A de novo gain-of-function mutation in SCN11A causes loss of pain perception , 2013, Nature Genetics.

[18]  X. Breakefield,et al.  Rapid‐onset dystonia–parkinsonism: Linkage to chromosome 19q13 , 1999, Annals of neurology.

[19]  C. Ross,et al.  A novel recurrent mutation in ATP1A3 causes , 2014 .

[20]  Paul Flicek,et al.  The functional spectrum of low-frequency coding variation , 2011, Genome Biology.

[21]  M. Rieder,et al.  Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. , 2013, American journal of human genetics.

[22]  R. Appleton,et al.  Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. , 1996, Journal of medical genetics.

[23]  Birgit Zirn,et al.  Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study , 2012, The Lancet Neurology.